Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany

J Hosp Infect. 1999 Jul;42(3):193-200. doi: 10.1053/jhin.1999.0597.

Abstract

In order to prevent the spread of vancomycin-resistant enterococci (VRE), the epidemiology of this micro-organism must be defined. The prevalence of colonization with VRE in various population groups in Berlin was investigated and the risk factors associated with VRE colonization assessed. In a cross-sectional study, rectal swabs were taken from seven population groups (healthy students, outpatients, home nursing patients, normal care and critical care patients of a community hospital and university hospital). Every one completed a questionnaire (age, gender, previous hospital stays, antibiotic therapy). Rectal swabs were examined for the presence of normal gut flora and VRE. All VRE isolates were typed by pulsed-field gel electrophoresis (PFGE). VRE colonization prevalence ranged from 0.9% (students) to 4.2% (nursing-home patients) in non-hospitalized subjects; in hospitalized patients prevalence ranged from 1.8% (regular care ward of a community hospital) to 16.3% (ICU patients of a university hospital). Location (university hospital, OR = 3.5) and age (> or = 60 years, OR = 2.2) were independent risk factors for VRE colonization. Within one population group, isolates with identical PFGE patterns were found in up to three people; one strain was found in four subjects belonging to different groups. Our findings suggest that VRE are imported from the community into hospitals with subsequent spread within the institution.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / antagonists & inhibitors*
  • Bacterial Typing Techniques
  • Berlin / epidemiology
  • Carrier State / epidemiology*
  • Carrier State / microbiology
  • Drug Resistance, Microbial
  • Enterococcus / classification
  • Enterococcus / drug effects*
  • Enterococcus / isolation & purification
  • Female
  • Gram-Positive Bacterial Infections / epidemiology*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Urban Population* / statistics & numerical data
  • Vancomycin / antagonists & inhibitors*

Substances

  • Anti-Bacterial Agents
  • Vancomycin